Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19509275 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer
Condition: Locally Recurrent or Metastatic Breast Cancer
Interventions: Drug: Imetelstat sodium;   Drug: Bevacizumab;   Drug: Paclitaxel

Study has passed its completion date and status has not been verified in more than two years.